tiprankstipranks
Trending News
More News >

Rakovina Therapeutics Plans Amendments to Debentures and Warrants

Story Highlights
Rakovina Therapeutics Plans Amendments to Debentures and Warrants

Don’t Miss TipRanks’ Half-Year Sale

Rakovina Therapeutics Inc ( (TSE:RKV) ) has provided an announcement.

Rakovina Therapeutics Inc. announced its intention to amend the terms of its outstanding convertible debentures and warrants. The proposed amendments include extending the maturity date, reducing the conversion price for debentures, and altering the exercise price and term for warrants. These changes are subject to approval by the TSX Venture Exchange and relevant stakeholders, aiming to enhance financial flexibility and align with market conditions.

More about Rakovina Therapeutics Inc

Rakovina Therapeutics Inc. operates in the biotechnology industry, focusing on developing innovative cancer treatments. The company is engaged in research and development to create effective therapeutic solutions for cancer patients.

Average Trading Volume: 46,276

Technical Sentiment Signal: Sell

Current Market Cap: C$13.94M

For detailed information about RKV stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1